Description
Bumetanide (bumetanide) is a loop diuretic listed in our Heart and blood pressure medications directory and prescribed for heart failure and fluid retention (1.1) (2.1). Administered via the oral route, Bumetanide is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Bumetanide is a medication containing the active pharmaceutical ingredient bumetanide, classified pharmacologically as a loop diuretic (2.1). It is clinically indicated for the management of heart failure and fluid retention as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Heart and blood pressure medications section of our catalogue, patients and prescribers frequently review Bumetanide alongside related therapies such as Bumex (Bumetanide), Demadex (Torsemide), Edecrin (Ethacrynic Acid), and Furosemide.
Official Indications and Usage
Indications and usage Bumetanide tablets, USP are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide tablets, USP following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity. (1.1)
Mechanism of Action
It changes the kidney’s handling of salt and water. Fluid balance and electrolyte monitoring can be important. (2.1)
What is Heart failure?
Heart failure means the heart does not fill or pump as effectively as the body needs. Symptoms and treatment differ by the underlying heart problem. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Heart failure condition guide for appointment questions and related therapies (2.1).
What is Edema and fluid retention?
Edema is swelling caused by fluid accumulating in tissues. Heart, kidney, vein, liver, and medicine-related causes require different assessment. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Edema and fluid retention condition guide for appointment questions and related therapies (2.1).
Ordering Bumetanide from Canada for U.S. Delivery
U.S. patients can order Bumetanide (Bumetanide) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Bumetanide |
| Chemical / Generic Name | Bumetanide |
| Pharmacological Class | Loop Diuretic |
| Therapeutic Category | Heart and blood pressure medications |
| Same-Ingredient Catalogue Entries | Bumex (Bumetanide) |
| Molecular Weight | 364.42, g/mol (2.1) |
| Elimination Half-Life | ~6 hours (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NLM MedlinePlus |
| Routes of Administration | Oral |
| Primary Indications | Heart Failure And Fluid Retention |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| FDA UNII Identifier | 0Y2S3XUQ5H |
| NLM RxNorm Concept ID (RxCUI) | 197419 |
| FDA Application License | ANDA074700 |
| Official DailyMed SetID | 0fb78afc-d8bc-4ae8-8c0a-6d9c6f7a22c5 |
| Catalogue Index Links | Letter B Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Dosage and administration Individualize dosage with careful monitoring of patient response. Oral Administration The usual total daily dosage of bumetanide tablets is 0.5 mg to 2 mg and in most patients is given as a single dose. If the diuretic response to an initial dose of bumetanide tablets is not adequate, in view of its rapid onset and short duration of action, a second or third dose may be given at 4- to 5- hour intervals up to a maximum daily dose of 10 mg. An intermittent dose schedule, whereby bumetanide tablets are given on alternate days or for 3 to 4 days with rest periods of 1 to 2 days in between, is recommended as the safest and most effective method for the continued control of edema. In patients with hepatic failure, keep the dosage to a minimum. (1.1)
Administration Guidance
Take Bumetanide orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.
Missed Dose Guidance
If you miss a scheduled dose of Bumetanide, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Bumetanide is bumetanide (2.1). Other catalogue entries containing bumetanide include Bumex (Bumetanide).
Inactive Ingredients (Excipients)
According to the U.S. FDA product labeling, formulation excipients include anhydrous lactose, corn starch, magnesium stearate, microcrystalline cellulose, pregelatinized starch (corn), talc, with the following dye systems: 0 (1.1). Inactive ingredients can vary slightly between different manufacturers and international or generic presentations; review the dispensed carton if you have known excipient sensitivities.
Cautions and important safety information
Boxed Warning
Warning Bumetanide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. Therefore, careful medical supervision is required, and dose and dosage schedule have to be adjusted to the individual patient’s needs. (1.1)
Contraindications
Contraindications Bumetanide is contraindicated in anuria. Although bumetanide can be used to induce diuresis in renal insufficiency, any marked increase in blood urea nitrogen or creatinine, or the development of oliguria during therapy of patients with progressive renal disease, is an indication for discontinuation of treatment with bumetanide. Bumetanide is also contraindicated in patients in hepatic coma or in states of severe electrolyte depletion until the condition is improved or corrected. Bumetanide is contraindicated in patients hypersensitive to this drug. (1.1)
Key Clinical Precautions
Before starting or continuing Bumetanide, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Heart failure: Fluid retention or cardiovascular workload changes may precipitate or worsen congestive heart failure in susceptible patients. Report sudden weight gain, shortness of breath, or ankle and leg swelling to your healthcare provider.
- Fetal toxicity and pregnancy considerations: This medication may cause fetal harm when administered to a pregnant patient. Discuss pregnancy planning, effective contraception, and safe treatment alternatives with your healthcare provider.
- Hypersensitivity and anaphylaxis: Serious allergic reactions, including anaphylaxis, angioedema, and severe rash, have been reported. Discontinue use and seek immediate medical care if swelling of the face, lips, tongue, or throat or difficulty breathing occurs.
- Renal function and acute kidney injury: Changes in serum creatinine or estimated glomerular filtration rate (eGFR) can occur, particularly in patients with volume depletion, chronic kidney disease, or concomitant use of NSAIDs, ACE inhibitors, ARBs, or diuretics. Renal function should be assessed prior to initiation and periodically thereafter.
Pregnancy, Lactation, and Special Populations
Pregnancy Teratogenic Effects Bumetanide is neither teratogenic nor embryocidal in mice when given in doses up to 3400 times the maximum human therapeutic dose. Bumetanide has been shown to be nonteratogenic, but it has a slight embryocidal effect in rats when given in doses of 3400 times the maximum human therapeutic dose and in rabbits at doses of 3.4 times the maximum human therapeutic dose. In one study, moderate growth retardation and increased incidence of delayed ossification of sternebrae were observed in rats at oral doses of 100 mg/kg/day, 3400 times the maximum human therapeutic dose. These effects were associated with maternal weight reductions noted during dosing. (1.1)
Interactions
Always provide your prescribing physician and pharmacist with an up-to-date list of all prescription medications, over-the-counter products, vitamins, and herbal supplements you take before starting Bumetanide (2.1).
Side effects
Like all medications, Bumetanide can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Xerostomia (dry mouth): Sipping water or using sugar-free lozenges can help relieve oral dryness.
Clinical Trial and Postmarketing Adverse Reactions
Adverse reactions The most frequent clinical adverse reactions considered probably or possibly related to bumetanide are muscle cramps (seen in 1.1% of treated patients), dizziness (1.1%), hypotension (0.8%), headache (0.6%), nausea (0.6%) and encephalopathy (in patients with pre-existing liver disease) (0.6%). One or more of these adverse reactions have been reported in approximately 4.1% of patients treated with bumetanide. Serious skin reactions (i.e., Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported in association with bumetanide use. Less frequent clinical adverse reactions to bumetanide are impaired hearing (0.5%), pruritus (0.4%), electrocardiogram changes (0.4%), weakness (0.2%), hives (0.2%), abdominal pain (0.2%), arthritic pain (0.2%), musculoskeletal pain (0.2%), rash (0.2%) and vomiting (0.2%). (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Bumetanide Tablets, USP, for oral administration, are available as 2 mg Beige to light brown, round, biconvex, bisected and debossed “E” above and “130” below the bisect on one side and plain on the reverse side. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure, as required. Keep tightly closed. (1.1)
Store Bumetanide in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
What is a generic drug?
A generic medication contains the exact same active pharmaceutical ingredient (bumetanide) as its brand-name counterpart and is formulated to deliver the same dosage strength, route of administration, safety profile, quality, and therapeutic performance (2.1). Regulatory authorities require generic manufacturers to demonstrate bioequivalence, meaning the generic medication releases its active ingredient into the bloodstream at virtually the same rate and to the same extent as the innovator brand.
While a generic tablet, capsule, or inhaler may differ in color, shape, scoring, or packaging due to trademark laws that govern brand appearance, its clinical mechanism and active ingredient match the reference medicine. Because generic manufacturers do not repeat the initial discovery and multi-phase clinical trial investments of the original brand, generic equivalents offer substantial cost savings for patients paying out of pocket.
Canadian Pharmacy Store delivers prescription and over-the-counter medications to U.S. residents. Browse our Heart and blood pressure medications directory, explore all medications A-Z, review how ordering works and prescription requirements, or call 1-888-868-1920 for personal assistance matching your prescription.
Related Medications in Our Catalogue
- Bumex (Bumetanide), listed in Heart and blood pressure medications
- Demadex (Torsemide), listed in Heart and blood pressure medications
- Edecrin (Ethacrynic Acid), listed in Heart and blood pressure medications
- Furosemide, listed in Heart and blood pressure medications
- Apixaban, listed in Heart and blood pressure medications
- Crestor (Rosuvastatin Calcium), listed in Heart and blood pressure medications
Related Categories, Directories, and Ordering Guides
- Heart and blood pressure medications Category Directory
- Medications Starting with B
- Active Ingredient Directory
- What to prepare before a prescription order
- How to compare prescription prices without mixing up the product
- How to Order Prescription Medication
- Prescription Requirements
- Ordering Medication from Canada Guide
- Caregiver Ordering Guide
- Explore Medications
- Explore Categories
Frequently Asked Questions About Bumetanide
What is Bumetanide and what active ingredient does it contain?
Bumetanide is a loop diuretic containing the active pharmaceutical ingredient bumetanide. It is supplied for oral administration and requires a valid prescription where applicable.
How does Bumetanide work in the body?
It changes the kidney’s handling of salt and water. Fluid balance and electrolyte monitoring can be important.
What conditions is Bumetanide prescribed to treat?
Bumetanide is primarily indicated for heart failure and fluid retention. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Bumetanide?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Bumetanide is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Bumetanide?
Commonly reported side effects of Bumetanide include feeling sick, vomiting, loose stools, headache, dizziness, and dry mouth. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Bumetanide?
Share your full list of current prescription medications, over-the-counter products, and supplements with your prescriber and pharmacist so they can screen for any potential drug interactions.
Can Bumetanide be used during pregnancy or breastfeeding?
Official prescribing information highlights pregnancy-related precautions for Bumetanide. Inform your healthcare provider immediately if you are pregnant, planning to become pregnant, or breastfeeding so safe treatment options can be evaluated.
Do I need a prescription to buy Bumetanide online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Bumetanide (Bumetanide) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
What is the brand-name version of Bumetanide (Bumetanide) at a Canada pharmacy?
Yes. Bumetanide is the bioequivalent generic formulation of brand-name Bumex, containing the same active ingredient (Bumetanide) and strength options.
Brand: Bumex
How is Bumetanide shipped to U.S. residents, and how much does shipping cost?
Bumetanide ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Bumetanide prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Bumetanide prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Bumetanide are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Bumetanide. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) MedlinePlus Medical Encyclopedia: Heart Failure. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (3.1) MedlinePlus Medical Encyclopedia: Edema. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
